## Abstract We assessed the clinical impact of MMPβ9 expression on longβterm survival in patients with operable nonβsmall cell lung cancer (NSCLC). Primary tumors of 143 consecutive patients with NSCLC resected completely and without overt distant metastases (pT1β4, pN0β2, M0, R0) were examined for
Prognostic impact of S100A9 overexpression in non-small cell lung cancer
β Scribed by Hideki Kawai; Yoshihiro Minamiya; Naoko Takahashi
- Publisher
- S. Karger AG
- Year
- 2011
- Tongue
- English
- Weight
- 255 KB
- Volume
- 32
- Category
- Article
- ISSN
- 1010-4283
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Lung cancer is still the leading cause of death from cancer worldwide primarily because of the fact that most lung cancers are diagnosed at advanced stages. Overexpression of the high mobility group protein HMGA2 has been observed in a variety of malignant tumors and often correlates wi
## Abstract S100A2, a calciumβbinding protein, recently became of major interest because of its differential expression during transformation and metastasis in various tumors. The purpose of this study was to investigate the prognostic significance of S100A2 expression in the earlyβstage non small
## Abstract ## Background The purpose of the present study was to assess the value of matrix metalloproteinase (MMP)β2 and MMPβ9 expression and other potential prognostic factors in predicting the clinical outcome of patients after definitive surgery for pathologic stage IA nonβsmall cell lung can
Increased production of immunosuppressive interleukin-10 (IL-10) by non-small cell lung cancer (NSCLC) and increased serum IL-10 concentrations in NSCLC-patients have recently been correlated to reduced survival. We earlier demonstrated suppression of IL-2 secretion in whole blood cell cultures of N